Efficacy of Respiratory Rehabilitation After COVID-19 Severe Infection
NCT ID: NCT05307562
Last Updated: 2024-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
24 participants
INTERVENTIONAL
2021-08-10
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Respiratory Muscle Training in Individuals With Long-term Post-COVID-19 Symptoms
NCT05597774
Evaluation of Effectiveness of Proprietary Rehabilitation Program in Patients After COVID-19 Infection
NCT05449379
Follow-up and Rehabilitation of Survivors of Severe Coronavirus Disease 2019 (COVID-19) Infection
NCT04563156
Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease
NCT04734561
Effects of Inspiratory Muscle Training After Covid-19 (ReCOV)
NCT05024474
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training program
Global intervallic exercise using cyclometer and analytical strength exercises
Interval training + analytical strength
Patients will receive a training program
Training program + Inspiratory muscle traioning (IMT)
Global intervallic exercise using cyclometer and analytical strength exercises + inspiratory muscles training
Interval training + analytical strength and IMT
Patients will receive a training program + IMT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interval training + analytical strength
Patients will receive a training program
Interval training + analytical strength and IMT
Patients will receive a training program + IMT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients discharged from the Pulmonology Service with a diagnosis of COVID-19 by positive PCR and with severe pneumonia.
* At least three months after the presence of at least one of the following criteria:
1. MRC dyspnea greater than or equal to 2.
2. Decrease in the meters walked with respect to the reference values in the 6-minute walking test.
C) Decreased respiratory muscle strength measured at Maximum Inspiratory Pressure (PIM) and / or Maximum Expiratory Pressure (PEM) with respect to reference values.
* Sign informed consent from the study
Exclusion Criteria
* Pregnant women.
* Impossibility to perform ergometry or ultrasound.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gerard Muñoz
Principal Investigator. PhD, PT
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerard Muñoz, PhD
Role: PRINCIPAL_INVESTIGATOR
Girona Biomedical Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Josep Trueta University Hospital
Girona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVFIS2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.